Practice
Featured experience
FTC clearance of Novo Nordisk acquisition of certain Catalent sites
We secured regulatory approval following a lengthy review
Syngenta antitrust litigation victory
We secured the dismissal of a price-fixing antitrust suit
Favorable plea deal for paving company in bid-rigging case
We represented the defendant in a DOJ antitrust investigation, securing a favorable plea deal
Antitrust advice to AI company
We are advising our client on a range of antitrust issues
Schellman strategic investment from Goldman Sachs Alternatives
We are advising Lightyear Capital and Schellman on the transaction
One Call acquisition of Data Dimensions
We are advising One Call on the transaction
Anthology chapter 11 restructuring
We advised an ad hoc group of creditors on the restructuring
Global Eggs investment of up to $1 billion from Warburg Pincus
We are advising Global Eggs on the transaction
Rhône Capital acquisition of Invacare
We advised Highbridge Capital, as an Invacare secured lender and noteholder, on the transaction
Leidos $2.4 billion acquisition of ENTRUST Solutions Group
We are advising Leidos on the transaction
Victory in World Aquatics antitrust litigation
We secured the dismissal of Sherman Act claims
AbelZeta sale of China rights to GPC3 CAR-T therapy to AstraZeneca
We advised AbelZeta on the transaction
Delinea acquisition of StrongDM
We are advising TPG and Delinea on the transaction
Penumbra $14.5 billion sale to Boston Scientific
We are advising Penumbra on the transaction